Figure 2From: The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis Morphological examination of the effects of ATO and nilotinib on cell differentiation. Cells were treated with 1 μM ATO and 5 nM nilotinib alone or in combination for 72 h. The cells were stained with Wright-Giemsa, and cell morphology was examined under light microscope at 1000x magnification.Back to article page